Company Filing History:
Years Active: 2020-2022
Title: Ashishkumar Jayantilal Maheta: Innovator in Retinoid Research
Introduction
Ashishkumar Jayantilal Maheta is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit CYP26 enzymes. His work is crucial for advancing treatments for diseases responsive to retinoids.
Latest Patents
Maheta holds 2 patents related to his innovative research. His latest patents include:
1. **Compounds and methods for inhibiting CYP26 enzymes** - This patent describes inhibitors of retinoic acid inducible P450 (CYP26) enzymes, which are useful for treating diseases that respond to retinoids. The compounds have retinoid activity and are resistant to CYP26-mediated catabolism.
2. **Compounds and methods for inhibiting CPY26 enzymes** - Similar to the first, this patent also focuses on inhibitors of CYP26 enzymes, emphasizing their utility in treating diseases responsive to retinoids.
Career Highlights
Maheta is affiliated with Queen's University at Kingston, where he conducts his research. His work has garnered attention for its potential impact on therapeutic strategies involving retinoids.
Collaborations
Some of his notable coworkers include Donald Andrew Cameron and Martin Petkovich. Their collaborative efforts contribute to the advancement of research in the field.
Conclusion
Ashishkumar Jayantilal Maheta is a prominent figure in the realm of retinoid research, with a focus on developing innovative compounds for medical applications. His contributions are paving the way for new treatments that could significantly benefit patients.